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Patientswithautosomaldominantpolycystickidneydiseasebecomesymptomaticandarediagnosedusuallyatadulthood.Therate
ofnephrolithiasisinthesepatientsis5–10timestherateinthegeneralpopulation,andbothanatomicandmetabolicabnormalities
play role in the formation of renal stones. However, nephrolithiasis is rare in childhood age group. In this paper, an 11-year-old
child with autosomal dominant polycystic kidney disease presenting with nephrolithiasis is discussed.
1.Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is
the most common hereditary kidney disease that is responsi-
ble for 8 to 10% of end-stage renal disease in adults [1, 2].
Although the disease might be diagnosed in the newborn
or early childhood periods, the symptomatic disease com-
monly presents during adulthood [1]. The prevalence of
nephrolithiasisamongADPKDpatientsis20%whichis5–10
times more than the general population [2]. In addition to
anatomic factors, metabolic abnormalities have also been
described in the pathogenesis of nephrolithiasis in these
patients. Nephrolithiasis is rare during childhood and
commonly develops after the age of 20 [3]. However, in
patients with known ADPKD presenting with ﬂank pain,
nephrolithiasis must be taken into consideration [4]. In this
paper we describe an 11-year-old child with ADPKD who
was presented with bloody urine and ﬂank pain. He was




inal pain and bloody urine following a mild abdominal
trauma. Physical examination was normal other than left
costovertebral angle tenderness including anthropometric
measurements and blood pressure. Urinalysis showed 3+
blood and 1+ protein with many isomorphic erythrocytes
in the microscopic evaluation of the sediment. Serum bio-
chemistry including renal and liver functions, electrolytes,
calcium, phosphorus, and alkaline phosphatase was normal.
Abdominal ultrasonography showed that both kidneys were
larger than normal and had numerous millimetric cysts.
There were bigger cysts at the upper pole of the right kidney
andupperandlowerpolesoftheleftkidneyreaching10mm,
12mm, and 13mm in diameter, respectively. In addition,
therewerenumerousmillimetriccalculiinbothkidneyswith
3largecalculiintheright(8,5,and5mm)andoneintheleft
(9mm) kidneys (Figure 1).
The patient’s family history revealed that his father, pa-
ternal uncle, and aunt had polycystic kidney disease. Fur-
thermore, his grandfather deceased due to chronic renal
failure, and his uncle was undergoing chronic hemodialysis
program.Allaﬀectedfamilymembershadrenalstonedisease
as well.
Metabolic investigations for urolithiasis were shown in
Table 1. Alltestresults werenormal excepturinary citrateex-
cretion which was at the lower limit of the normal range.
The patient was hospitalized, and parenteral hydration
was performed. His abdominal pain was controlled with2 Case Reports in Medicine
Figure 1: Cysts and calculi appear on USG.
Table 1: Metabolic evaluation for nephrolithiasis.
Test Result
24-hour urine
(i) Oxalate (i) 0.28mmol/1.73m2/24h (N: < 0.56)
(ii) Calcium (ii) 3.2mg/kg/24h (N:< 4)
(iii) Uric acid (iii) 9.4mg/kg/24h (N: < 10)
(iv) Citrate (iv) 2.0mg/kg/24h (N: > 2)
(v) Cystine (v) 35mg/1.73m2/24h (N: < 60)
Serum
(i) HCO3 (i) 24mmol/L (N: 22–28)
(ii) Uric acid (ii) 4.2mg/dL (N: 1.7–5.8)
(iii) Calcium (iii) 10.1mg/dL (N: 8.8–10.8)
paracetamol.Potassiumcitrate(2mmolHCO3
−/kg/day)was
prescribed for prophylaxis of nephrolithiasis. He passed a
stone in his urine at the 2nd month of followup. Stone anal-
ysis by X-ray diﬀraction method was consistent with calcium
oxalate calculus. Extracorporeal shock wave lithotripsy was
planned for the remaining stones.
3. Discussion
ADPKD is the most common hereditary kidney disease that
is responsible for 5 to 10% of end-stage renal disease in
adults. It has been shown that PKD1 (chromosome 16p13.3)
and PKD2 mutations (chromosome 4q13q23) are causative
in 85% and 15% of patients, respectively [1, 2]. In our case,
mutation analysis was not performed. However, it has been
reported that determination of 2 cysts in a single kidney or
one cyst in each kidney in a patient under 30 years of age in
a known ADPKD family is suﬃcient for diagnosis [5]. Thus,
our patient was considered to have ADPKD.
In ADPKD, along with the cystic alterations in the
kidneys, various extrarenal ﬁndings such as cysts in the
liver, spleen and ovary, mitral valve prolapses, intracranial
aneurysms, diverticulosis in the colon, and abdominal
hernias may be seen [4, 6]. Abdominal ultrasonography did
not reveal extrarenal cysts in our patient. On the other hand,
we did not screen for the presence of intracranial aneurysms
as the family history did not reveal any cerebrovascular
event [7].
Abdominal pain is a common symptom in ADKPD.
Acute pain may result from bleeding into the cysts, obstruc-
tion due to calculi,s or infection. Chronic abdominal pain
is associated with the pressure caused by the kidneys and/or
cysts. Nonnephrotoxic analgesics or cyst decompression or
sclerosis may be applied in the treatment of chronic pain [1].
In our case, abdominal pain and hematuria were probably
related to the presence of calculi. Hematuria disappeared
spontaneously, while the pain responded to paracetamol.
The prevalence of urolithiasis in ADPKD is around 20–
36 percent. Approximately half of the calculi is calcium
oxalate and the other half consists of uric acid [3]. However,
urolithiasis is rare in childhood and is usually seen after the
second decade of life. In a study of 82 ADPKD patients,
nephrolithiasis was detected in 23 (28%) patients. Forty
percent and 60% of the cases were 20 to 40 years and over
40 years of age, respectively. None of the patients below 20
years of age had urolithiasis [8]. Our case is interesting in
that he had 3 large and many small calculi while he was just
at 11 years of age.
Increased risk of urolithiasis in ADPKD is associated
with both intrarenal anatomic obstruction and urinary tract
infections. On the other hand, metabolic abnormalities
frequently accompany urolithiasis. Most common metabolic
abnormality is hypocitraturia, while hypercalciuria and
hyperuricosuria are having also been reported in some
cases [3]. Ultrasonographic and metabolic parameters were
compared in ADPKD patients having and not having renal
stone disease. It was reported that patients having calculus
had more and bigger cysts, while they had lower glomerular
ﬁltration rate, urine volume, urine phosphate, magnesium,
citrate, and potassium levels. In both groups of patients,
the rate of hypocitraturia was approximately 60 percent
[9]. Our patient is probably prone to the development of
urolithiasis due to the presence of numerous renal cysts and
hypocitraturia. On the other hand, it has been reported that
there are phenotypic diﬀerences in ADPKD families. The
prevalence of hypertension and hernia along with patient
and renal survivals diﬀers between the families [10]. All
eﬀected family members of our patient have renal stone
disease. This implicates that there may be a hereditary
predisposition for renal calculus disease in this family.
In conclusion, in patients with ADPKD, multiple factors
contribute to the development of urolithiasis including
anatomic, metabolic, and hereditary abnormalities. Presence
of nephrolithiasis in this 11-year-old child indicates the
importance of the evaluation and followup of even young
children with ADPKD for renal stone disease.
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